Epilepsy Research Today is a free monthly online journal that collates and summarizes the latest research about Epilepsy, including details on symptoms, causes, treatment, drugs, information.

Volume 2 (2005), Issue 7 (July)

1. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder.
   Nat Genet, 37(7): 733-8. [Abstract] [Full-text]
2. High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity.
   Prog Neuropsychopharmacol Biol Psychiatry, 29(5): 770-4. [Abstract] [Full-text]
3. Chronic treatment with fluoxetine decreases seizure threshold in naïve but not in rats exposed to the learned helplessness paradigm: Correlation with the hippocampal glutamate release.
   Prog Neuropsychopharmacol Biol Psychiatry, 29(5): 678-86. [Abstract] [Full-text]
4. Region-specific phosphorylation of ERK5-MEF2C in the rat frontal cortex and hippocampus after electroconvulsive shock.
   Prog Neuropsychopharmacol Biol Psychiatry, 29(5): 749-53. [Abstract] [Full-text]
5. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus.
   Brain Res, 1050(1): 130-7. [Abstract] [Full-text]
6. Unusual ipsilateral hyperkinetic automatisms in SMA seizures.
   Seizure, 14(5): 354-61. [Abstract] [Full-text]
7. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study.
   BMJ, 331(7507): 23. [Abstract] [Full-text]
8. Metabolic changes in rat striatum following convulsive seizures.
   Brain Res, 1050(1): 124-9. [Abstract] [Full-text]
9. Influence of aminoglutethimide and spironolactone on the efficacy of carbamazepine and diphenylhydantoin against amygdala-kindled seizures in rats.
   Eur J Pharmacol, 516(3): 212-8. [Abstract] [Full-text]
10. Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002.
    Hum Psychopharmacol, 20(5): 343-8. [Abstract] [Full-text]
11. Self-perception of factors that precipitate or inhibit seizures in juvenile myoclonic epilepsy.
    Seizure, 14(5): 340-6. [Abstract] [Full-text]
12. CNS depressant activity of Lecaniodiscus cupanioides.
    Fitoterapia, 76(5): 412-8. [Abstract] [Full-text]
13. Low-frequency transcranial magnetic stimulation for epilepsia partialis continua due to cortical dysplasia.
    J Neurol Sci, 234(1): 37-9. [Abstract] [Full-text]
14. Febrile seizures in the predisposed brain: a new model of temporal lobe epilepsy.
    Ann Neurol, 58(1): 41-9. [Abstract] [Full-text]
15. Frontal nonconvulsive status epilepticus manifesting somatic hallucinations.
    J Neurol Sci, 234(1): 25-9. [Abstract] [Full-text]
16. No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study.
    Seizure, 14(5): 362-6. [Abstract] [Full-text]
17. Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids.
    Neurosci Lett, 385(1): 13-7. [Abstract] [Full-text]
18. Seizure-related injuries in a group of young people with epilepsy wearing protective helmets: incidence, types and circumstances.
    Seizure, 14(5): 347-53. [Abstract] [Full-text]
19. Factors associated with academic achievement in children with recent-onset seizures.
    Seizure, 14(5): 331-9. [Abstract] [Full-text]
20. Did Fyodor Mikhailovich Dostoevsky suffer from mesial temporal lobe epilepsy?
    Seizure, 14(5): 324-30. [Abstract] [Full-text]
21. Sensitivity and specificity of procedures for the differential diagnosis of epileptic and non-epileptic seizures: a systematic review.
    Seizure, 14(5): 293-303. [Abstract] [Full-text]
22. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
    Seizure, 14(5): 312-7. [Abstract] [Full-text]
23. Outcomes in newly diagnosed localization-related epilepsies.
    Seizure, 14(5): 318-23. [Abstract] [Full-text]
24. Epileptic seizures, epilepsy and epileptic syndromes in newborns: a nosological approach to 94 new cases by the 2001 proposed diagnostic scheme for people with epileptic seizures and with epilepsy.
    Seizure, 14(5): 304-11. [Abstract] [Full-text]
25. Approach to the patient with epilepsy in the outpatient department.
    Postgrad Med J, 81(957): 442-7. [Abstract] [Full-text]
26. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Curr Med Res Opin, 21(7): 1065-8. [Abstract] [Full-text]
27. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment.
    Neurochem Int, 47(4): 248-59. [Abstract] [Full-text]
28. Anticonvulsant effects of the wasp Polybia ignobilis venom on chemically induced seizures and action on GABA and glutamate receptors.
    Comp Biochem Physiol C Toxicol Pharmacol, 141(1): 50-7. [Abstract] [Full-text]
29. Open radiofrequency ablation for the management of intractable epilepsy associated with sessile hypothalamic hamartoma.
    Minim Invasive Neurosurg, 48(3): 132-5. [Abstract] [Full-text]
30. Victoria symptom validity test performance in non-litigating epilepsy surgery candidates.
    J Clin Exp Neuropsychol, 27(5): 610-7. [Abstract] [Full-text]
31. Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis.
    J Neurol Neurosurg Psychiatry, 76(8): 1080-3. [Abstract] [Full-text]
32. Post-seizures amygdaloallocortical microvascular lesion leading to atrophy and memory impairment.
    Neurobiol Dis, 19(3): 479-89. [Abstract] [Full-text]
33. Entorhinal cortex entrains epileptiform activity in CA1 in pilocarpine-treated rats.
    Neurobiol Dis, 19(3): 451-60. [Abstract] [Full-text]
34. Increased number of neural progenitors in human temporal lobe epilepsy.
    Neurobiol Dis, 19(3): 436-50. [Abstract] [Full-text]
35. An analysis of epilepsy with chromosomal abnormalities.
    Brain Dev, 27(5): 370-7. [Abstract] [Full-text]
36. Seizure and EEG patterns in Wolf-Hirschhorn (4p-) syndrome.
    Brain Dev, 27(5): 362-4. [Abstract] [Full-text]
37. Comparison of two low dose ACTH therapies for West syndrome: their efficacy and side effect.
    Brain Dev, 27(5): 326-30. [Abstract] [Full-text]
38. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial.
    Lancet, 366(9481): 205-10. [Abstract] [Full-text]
39. Susceptibility to seizure-induced injury and acquired microencephaly following intraventricular injection of saporin-conjugated 192 IgG in developing rat brain.
    Exp Neurol, 194(2): 457-66. [Abstract] [Full-text]
40. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.
    Exp Neurol, 194(2): 355-62. [Abstract] [Full-text]
41. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
    Epilepsy Behav, 7(1): 18-36. [Abstract] [Full-text]
42. Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy.
    Epilepsy Behav, 7(1): 116-22. [Abstract] [Full-text]
43. Epilepsy-associated stigma in sub-Saharan Africa: the social landscape of a disease.
    Epilepsy Behav, 7(1): 68-73. [Abstract] [Full-text]
44. Lateralizing signs during seizures in focal epilepsy.
    Epilepsy Behav, 7(1): 1-17. [Abstract] [Full-text]
45. The potential value of three-dimensional accelerometry for detection of motor seizures in severe epilepsy.
    Epilepsy Behav, 7(1): 74-84. [Abstract] [Full-text]
46. Prenatal corticosteroid impact on hippocampus: implications for postnatal outcomes.
    Epilepsy Behav, 7(1): 57-67. [Abstract] [Full-text]
47. Psychiatric comorbidity in epilepsy.
    Epilepsy Behav, 7(1): 37-50. [Abstract] [Full-text]
48. Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement.
    Neurosci Lett, 385(3): 184-8. [Abstract] [Full-text]
49. Evolution of seizures and electroencephalographical findings in 23 cases of deletion type Angelman syndrome.
    Brain Dev, 27(5): 383-8. [Abstract] [Full-text]
50. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy.
    Epilepsy Behav, 7(1): 98-105. [Abstract] [Full-text]
51. The h-channel: a potential channelopathy in epilepsy?
    Epilepsy Behav, 7(1): 51-6. [Abstract] [Full-text]
52. Stigma and safe havens: a medical sociological perspective on African-American female epilepsy patients.
    Epilepsy Behav, 7(1): 106-15. [Abstract] [Full-text]
53. Dreaming of seizures.
    Epilepsy Behav, 7(1): 127-8. [Abstract] [Full-text]
54. Antimitochondrial antibodies in patients with epilepsy.
    Epilepsy Behav, 7(1): 95-7. [Abstract] [Full-text]
55. Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorder.
    Epilepsy Behav, 7(1): 123-6. [Abstract] [Full-text]
56. The Brief Symptom Inventory (BSI) as a screening tool for psychological disorders in patients with epilepsy and mild intellectual disabilities in residential care.
    Epilepsy Behav, 7(1): 85-94. [Abstract] [Full-text]
57. Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the alpha 4 beta 2 nicotinic acetylcholine receptor.
    Mol Pharmacol, 68(2): 487-501. [Abstract] [Full-text]
58. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
    Epilepsia, 46(7): 1145-6. [Abstract] [Full-text]
59. Hyperglycemia with occipital seizures: images and visual evoked potentials.
    Epilepsia, 46(7): 1140-4. [Abstract] [Full-text]
60. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey.
    Epilepsia, 46(7): 1133-9. [Abstract] [Full-text]
61. Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey.
    Epilepsia, 46(7): 1127-32. [Abstract] [Full-text]
62. Epilepsy care in Zambia: a study of traditional healers.
    Epilepsia, 46(7): 1121-6. [Abstract] [Full-text]
63. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
    Epilepsia, 46(7): 1114-20. [Abstract] [Full-text]
64. A magnetoencephalographic study of patients with Panayiotopoulos syndrome.
    Epilepsia, 46(7): 1106-13. [Abstract] [Full-text]
65. Characteristics of slow waves on EEG associated with epileptic spasms.
    Epilepsia, 46(7): 1098-105. [Abstract] [Full-text]
66. Origin and propagation of epileptic spasms delineated on electrocorticography.
    Epilepsia, 46(7): 1086-97. [Abstract] [Full-text]
67. The first case of invasive EEG monitoring for the surgical treatment of epilepsy: historical significance and context.
    Epilepsia, 46(7): 1082-5. [Abstract] [Full-text]
68. Double-blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures.
    Epilepsia, 46(7): 1071-81. [Abstract] [Full-text]
69. Retinal electrophysiological results in patients receiving lamotrigine monotherapy.
    Epilepsia, 46(7): 1055-60. [Abstract] [Full-text]
70. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Epilepsia, 46(7): 1046-54. [Abstract] [Full-text]
71. Morphologic and neurochemical abnormalities in the auditory brainstem of the genetically epilepsy-prone hamster (GPG/Vall).
    Epilepsia, 46(7): 1027-45. [Abstract] [Full-text]
72. Volumetric magnetic resonance imaging of functionally relevant structural alterations in chronic epilepsy after pilocarpine-induced status epilepticus in rats.
    Epilepsia, 46(7): 1021-6. [Abstract] [Full-text]
73. Prolonged infusion of cycloheximide does not block mossy fiber sprouting in a model of temporal lobe epilepsy.
    Epilepsia, 46(7): 1017-20. [Abstract] [Full-text]
74. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
    Epilepsia, 46(7): 1010-6. [Abstract] [Full-text]
75. Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock.
    Eur J Neurosci, 21(12): 3229-39. [Abstract] [Full-text]
76. Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy.
    Eur J Neurosci, 22(1): 10-20. [Abstract] [Full-text]
77. Functional MRI of the pre-ictal state.
    Brain, 128: 1811-7. [Abstract] [Full-text]
78. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?
    Brain, 128: 1832-40. [Abstract] [Full-text]
79. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.
    Brain, 128: 1802-10. [Abstract] [Full-text]
80. The temporopolar cortex plays a pivotal role in temporal lobe seizures.
    Brain, 128: 1818-31. [Abstract] [Full-text]
81. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.
    Brain, 128: 1841-6. [Abstract] [Full-text]
82. Mechanisms underlying status epilepticus.
    Drugs Today (Barc), 41(4): 257-66. [Abstract] [Full-text]
83. The effects of sevoflurane and hyperventilation on electrocorticogram spike activity in patients with refractory epilepsy.
    Anesth Analg, 101(2): 517-23, table of contents. [Abstract] [Full-text]
84. A rapid increase in the inspired concentration of desflurane is not associated with epileptiform encephalogram.
    Anesth Analg, 101(2): 396-400, table of contents. [Abstract] [Full-text]
85. Is high cerebral perfusion pressure and cerebral flow predictive of impending seizures in preeclampsia? A case report.
    Hypertens Pregnancy, 24(1): 59-63. [Abstract] [Full-text]
86. Epidemiological survey of epilepsy in the primary school population in Buenos Aires.
    Neuroepidemiology, 25(2): 62-8. [Abstract] [Full-text]
87. Ketamine reduces lidocaine-induced seizures in mice.
    Int J Neurosci, 115(8): 1239-44. [Abstract] [Full-text]
88. Hemispheric integrative therapy in Landau-Kleffner syndrome: applications for rehabilitation sciences.
    Int J Neurosci, 115(8): 1227-38. [Abstract] [Full-text]
89. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
    Autoimmunity, 38(2): 139-50. [Abstract] [Full-text]
90. Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study.
    Epilepsy Res, 65(1): 93-100. [Abstract] [Full-text]
91. Association analysis of the Arg220His variation of the human gene encoding the GABA delta subunit with idiopathic generalized epilepsy.
    Epilepsy Res, 65(1): 53-7. [Abstract] [Full-text]
92. The role of adenosine A(1) receptors in the interaction between amygdala and entorhinal cortex of kindled rats.
    Epilepsy Res, 65(1): 1-9. [Abstract] [Full-text]
93. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors.
    Epilepsy Res, 65(1): 101-15. [Abstract] [Full-text]
94. Comparison of voxel-based 3-D MRI analysis and subtraction ictal SPECT coregistered to MRI in focal epilepsy.
    Epilepsy Res, 65(1): 125-33. [Abstract] [Full-text]
95. Clinical and EEG phenotypes of epilepsy in the baboon (Papio hamadryas spp.).
    Epilepsy Res, 65(1): 71-80. [Abstract] [Full-text]
96. Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit.
    Epilepsy Res, 65(1): 41-51. [Abstract] [Full-text]
97. Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticus.
    Epilepsy Res, 65(1): 59-70. [Abstract] [Full-text]
98. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.
    Epilepsy Res, 65(1): 11-22. [Abstract] [Full-text]
99. The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors.
    Epilepsy Res, 65(1): 33-40. [Abstract] [Full-text]
100. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
     Epilepsy Res, 65(1): 23-31. [Abstract] [Full-text]
101. Flurothyl seizures susceptibility is increased in prenatally methamphetamine-exposed adult male and female rats.
     Epilepsy Res, 65(1): 121-4. [Abstract] [Full-text]
102. Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies.
     Acta Neuropathol (Berl), 110(1): 1-11. [Abstract] [Full-text]
103. Action potential fidelity during normal and epileptiform activity in paired soma-axon recordings from rat hippocampus.
     J Physiol, 566: 425-41. [Abstract] [Full-text]
104. Long QT syndrome presenting as epileptic seizures in an adult.
     Emerg Med J, 22(8): 600-1. [Abstract] [Full-text]
105. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy.
     Nat Neurosci, 8(8): 1059-68. [Abstract] [Full-text]
106. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report.
     Surg Neurol, 64(2): 170-3. [Abstract] [Full-text]
107. Increase of brain-stem high-frequency SEP subcomponents during light sleep in seizure-free epileptic patients.
     Clin Neurophysiol, 116(8): 1774-8. [Abstract] [Full-text]
108. A neural network method for automatic and incremental learning applied to patient-dependent seizure detection.
     Clin Neurophysiol, 116(8): 1785-95. [Abstract] [Full-text]
109. EEG nonstationarity during intracranially recorded seizures: statistical and dynamical analysis.
     Clin Neurophysiol, 116(8): 1796-807. [Abstract] [Full-text]
110. Hippocampal-orbitofrontal connectivity in human: an electrical stimulation study.
     Clin Neurophysiol, 116(8): 1779-84. [Abstract] [Full-text]

© 2004-2008 Epilepsy Research Today. All Rights Reserved.